Loading...
Skip to main content
The Impact Investor LogoThe Impact Investor Logo
Search for stocks by symbol or company name. Use arrow keys to navigate suggestions.
AI Assistant
The Impact Investor Logo

Empowering retail investors to invest responsibly for their future while making a positive social impact.

Quick Links

  • Blog
  • ESG Stocks
  • Marketplace
  • Sectors
  • About Us

Newsletter

Join our newsletter to get updates on impact investing opportunities.

Privacy policy acceptance is required to subscribe

© 2025 The Impact Investor. All rights reserved.

Privacy Policy | Disclaimer
  1. Home
  3. Industries
10 Best Biotechnology Industry Stocks to Invest in Today | ESG Analysis | The Impact Investor
  1. Home
  3. Industries
  5. Biotechnology

Best Biotechnology Industry Stocks to Invest in Today

Discover the top-performing companies in the biotechnology industry that combine strong returns with positive social impact. Explore 10 carefully selected stocks with real-time data and ESG ratings.

Data updated in real-time • 10 stocks analyzed • ESG ratings included

Biotechnology Industry Analysis

Biotechnology companies advancing innovative therapies, diagnostic solutions, and medical technologies.

Industry Statistics

Companies Analyzed10
Total Market Companies9
Avg. Market Cap$96.7B

Growth Drivers

Precision medicine advancement, gene therapy breakthroughs, aging population needs, rare disease focus, technology convergence, and collaborative research models.

Industry Overview

Biotechnology industry focuses on using biological processes to develop therapeutic drugs, diagnostic tools, and medical devices, with emphasis on rare diseases, personalized medicine, and breakthrough treatments.

Key Characteristics

Research-intensive operations, clinical trial dependencies, regulatory approval requirements, intellectual property focus, high-risk high-reward profiles, and scientific talent requirements.

ESG Considerations

Patient access to innovative therapies, orphan disease treatment, ethical clinical trials, global health initiatives, sustainable manufacturing, and transparent research practices.

Regulatory Environment

FDA biologics regulations, orphan drug incentives, clinical trial protocols, manufacturing quality standards, and international harmonization requirements.

Top Biotechnology Industry Stock Picks Today

Interactive table showing the best-performing stocks with ESG ratings and key financial metrics

Showing 1 to 10 of 10 stocks

Company
Price
Votes
Market Cap
ESG RatingAction
AbbVie Inc.
ABBV
$40.19
0
$1.1B60/100View Details →
Amgen Inc.
AMGN
$45.16
0
$1.1B81/100View Details →
Arcus Biosciences, Inc.
RCUS
$34.24
0
$1.7BN/AView Details →
Biogen
B11
$347.64
0
$6.2B71/100View Details →
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$427.43
0
$11.2B26/100View Details →
Emergent BioSolutions Inc.
EBS
$378.83
0
$17.7BN/AView Details →
Invitae Corporation
NVTA
$325.95
0
$6.8BN/AView Details →
Myovant Sciences Ltd.
MYOV
$440.39
0
$20.2B51/100View Details →
SQZ Biotechnologies Company
SQZ
$56.12
0
$593.4MN/AView Details →
Zymeworks Inc.
ZYME
$423.62
0
$16.7BN/AView Details →
AbbVie Inc.
ABBV
ESG: 60/100
Price:$40.19
Votes:0
Market Cap:$1.1B
View Complete Analysis
Amgen Inc.
AMGN
ESG: 81/100
Price:$45.16
Votes:0
Market Cap:$1.1B
View Complete Analysis
Arcus Biosciences, Inc.
RCUS
Price:$34.24
Votes:0
Market Cap:$1.7B
View Complete Analysis
Biogen
B11
ESG: 71/100
Price:$347.64
Votes:0
Market Cap:$6.2B
View Complete Analysis
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
ESG: 26/100
Price:$427.43
Votes:0
Market Cap:$11.2B
View Complete Analysis
Emergent BioSolutions Inc.
EBS
Price:$378.83
Votes:0
Market Cap:$17.7B
View Complete Analysis
Invitae Corporation
NVTA
Price:$325.95
Votes:0
Market Cap:$6.8B
View Complete Analysis
Myovant Sciences Ltd.
MYOV
ESG: 51/100
Price:$440.39
Votes:0
Market Cap:$20.2B
View Complete Analysis
SQZ Biotechnologies Company
SQZ
Price:$56.12
Votes:0
Market Cap:$593.4M
View Complete Analysis
Zymeworks Inc.
ZYME
Price:$423.62
Votes:0
Market Cap:$16.7B
View Complete Analysis
10
Total Stocks
10
With Pricing Data
5
ESG Rated
0
Avg. Votes

Why Invest in Biotechnology Industry Stocks?

Growth Potential

Biotechnology industry showing strong market fundamentals. The biotechnology industry presents compelling opportunities for investors seeking both financial returns and positive impact.

Sustainable Impact

Companies in this industry are focusing on sustainable practices. Companies in this industry are increasingly focusing on environmental stewardship and social responsibility.

Investment Merit

Attractive investment opportunities with ESG alignment. Our analysis of 10 stocks reveals strong fundamentals combined with ESG excellence.

Market Context: The biotechnology industryhas demonstrated resilience and innovation, particularly in adapting to ESG principles. Recent trends show increasing investor interest in sustainable practices within this space, making it an attractive area for impact-conscious investors seeking both returns and positive change.

How to Start Investing in Biotechnology Industry Stocks

A simple 3-step guide to begin your biotechnology industry investment journey

1

Choose a Brokerage

Open an account with a reliable trading platform that offers fractional shares for biotechnology industry stocks.

Commission-free trades
Fractional shares available
Strong research tools
2

Diversify & Allocate

Don't put all funds in one stock. Consider spreading investments across multiple biotechnology companies or related ETFs.

Reduce risk
Multiple opportunities
Balanced exposure
3

Monitor & Learn

Stay informed about market trends, ESG developments, and company performance through our regular updates.

Weekly insights
ESG analysis
Market trends

Investment Tips for Biotechnology Industry Stocks

Start Small

Begin with amounts you're comfortable with. Most brokerages allow investments as low as $1 with fractional shares.

Think Long-Term

ESG investing often rewards patience. Focus on companies with sustainable business models and strong fundamentals.

Stay Informed

Follow earnings reports, ESG initiatives, and industry trends to make informed decisions about your holdings.

Review Regularly

Assess your portfolio quarterly, but avoid daily monitoring which can lead to emotional decision-making.

Important Disclaimer: This content is for educational purposes only and should not be considered personalized investment advice. Investing involves risk, including potential loss of principal. Past performance does not guarantee future results. Please consult with a qualified financial advisor before making investment decisions.

Our Methodology for Selecting the Best Biotechnology Industry Stocks

Transparent, data-driven approach to identifying top-performing ESG stocks

Financial Performance

Revenue growth, profitability, debt-to-equity ratios, and analyst consensus ratings

ESG Excellence

MSCI ESG ratings, Sustainalytics scores, and environmental/social governance practices

Real-Time Data

Live pricing from Alpha Vantage API, updated financial metrics, and market performance

Market Leadership

Industry position, competitive advantages, and innovation in sustainable practices

Data Sources & Transparency

Our analysis combines real-time financial data from Alpha Vantage API, ESG ratings from MSCI and Sustainalytics, and fundamental data stored in our PostgreSQL database.

All stock selections undergo quarterly review to ensure continued alignment with our ESG standards and financial performance criteria. We maintain independence in our analysis and clearly disclose any affiliate relationships.

Disclosure: Some links on this page are affiliate links. We may earn a commission if you sign up for services through these links, but this does not influence our stock selections or recommendations.

Real-Time Updates

Stock prices and key metrics are updated in real-time during market hours. ESG ratings are reviewed monthly to reflect the latest sustainability assessments.

Frequently Asked Questions about Biotechnology Industry Stocks

Common questions from investors interested in biotechnology industry investing

The Biotechnology industry is positioned for continued growth driven by technological innovation, sustainability initiatives, and changing consumer preferences. Industry analysts project strong fundamentals with increasing focus on ESG practices. Companies in this industry are adapting to regulatory changes and market demands for more sustainable business models.

Have more questions? Feel free tocontact our team orsubscribe to our newsletter for regular updates and insights on biotechnology industry investing.

Stay Updated on Biotechnology Industry Investing

Join 5,000+ investors who receive our weekly insights on the best biotechnology industry stocks, market trends, and ESG developments.

Weekly stock picks and market analysis
Exclusive ESG insights and ratings updates
Early access to new investment opportunities

🔒 No spam, unsubscribe anytime. We respect your privacy and never share your email.

5,000+
Subscribers
94%
Open Rate
Weekly
Insights
Free
Forever